• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
94348
INE1BZN01016
58.5748291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CURIS
12.86
89.09
EPS(TTM)
Face Value()
Div & Yield %
8.57
10
0
 

accedere ltd
Accedere reports consolidated net profit of Rs 0.63 crore in the March 2026 quarter
May 30,2026
Net profit of Accedere reported to Rs 0.63 crore in the quarter ended March 2026 as against net loss of Rs 0.02 crore during the previous quarter ended March 2025. Sales rose 86.67% to Rs 1.68 crore in the quarter ended March 2026 as against Rs 0.90 crore during the previous quarter ended March 2025.

For the full year,net profit rose 265.00% to Rs 0.73 crore in the year ended March 2026 as against Rs 0.20 crore during the previous year ended March 2025. Sales rose 13.70% to Rs 4.15 crore in the year ended March 2026 as against Rs 3.65 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.680.90 87 4.153.65 14
OPM %51.79-16.67 -26.274.93 -
PBDT0.91-0.05 LP 1.120.28 300
PBT0.71-0.07 LP 0.840.14 500
NP0.63-0.02 LP 0.730.20 265